HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pentosidine plasma levels and relation with metabolic control in diabetic patients.

Abstract
Levels of plasma pentosidine, a well-known AGE, were measured in type 2 diabetic patients in varying states of metabolic control to verify possible relationships between this parameter and traditional metabolic control parameters such as HbA1c and plasma glucose levels. At baseline, mean values of fasting plasma glucose, HbA1c and pentosidine were significantly higher in diabetic patients than those of controls, confirming patients' poor glycemic control. After ten months, patients with good metabolic control achieved showed near-normal HbA1c levels and reduced but not normalized pentosidine levels. Significant differences were found in the mean percentage decrease in the parameters. Regarding linear correlation, HbA1c levels only showed a positive relationship with plasma glucose values at baseline. Patients affected by chronic complications showed higher levels of pentosidine than those without complications. Thus, pentosidine plasma levels may be used to evaluate very long-term metabolic control in diabetic patients. In addition, a period of ten months of acceptable metabolic control is not enough to normalize pentosidine levels in diabetics, thus emphasizing the need for a longer period of improved metabolic control to reduce both this parameter and the burden of chronic diabetic complications.
AuthorsA Lapolla, R Reitano, L Baccarin, G Sartore, M Plebani, D Fedele
JournalHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme (Horm Metab Res) Vol. 37 Issue 4 Pg. 252-6 (Apr 2005) ISSN: 0018-5043 [Print] Germany
PMID15952087 (Publication Type: Journal Article)
Chemical References
  • Blood Glucose
  • Glycated Hemoglobin A
  • Glycation End Products, Advanced
  • Hypoglycemic Agents
  • Arginine
  • pentosidine
  • Lysine
Topics
  • Aged
  • Arginine (analogs & derivatives, blood)
  • Blood Glucose (metabolism)
  • Blood Glucose Self-Monitoring
  • Chromatography, Liquid
  • Diabetes Complications (blood, epidemiology)
  • Diabetes Mellitus, Type 2 (blood, drug therapy, metabolism)
  • Female
  • Glycated Hemoglobin (metabolism)
  • Glycation End Products, Advanced (blood)
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Linear Models
  • Lysine (analogs & derivatives, blood)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: